美国过敏、哮喘与免疫学学会 2024 年会议上 CEGIR/TIGERs 研讨会呈现的嗜酸性粒细胞性胃肠道疾病的进展和持续挑战。
Advances and ongoing challenges in eosinophilic gastrointestinal disorders presented at the CEGIR/TIGERs Symposium at the 2024 American Academy of Allergy, Asthma & Immunology meeting.
机构信息
Department of Medicine, Division of Allergy, Asthma, and Clinical Immunology, Mayo Clinic Arizona, Scottsdale, Ariz; Division of Allergy and Immunology, Phoenix Children's Hospital, Phoenix, Ariz.
Department of Pediatrics, Division of Allergy and Immunology, Cincinnati Children's Hospital Medical Center, University of Cincinnati College of Medicine, Cincinnati, Ohio.
出版信息
J Allergy Clin Immunol. 2024 Oct;154(4):882-892. doi: 10.1016/j.jaci.2024.07.022. Epub 2024 Aug 5.
Abstract
The Consortium of Eosinophilic Gastrointestinal disease Researchers (CEGIR) and The International Gastrointestinal Eosinophil Researchers (TIGERs) organized a daylong symposium at the 2024 annual meeting of the American Academy of Allergy, Asthma & Immunology. The symposium featured new discoveries in basic and translational research as well as debates on the mechanisms and management of eosinophilic gastrointestinal diseases. Updates on recent clinical trials and consensus guidelines were also presented. We summarize the updates on eosinophilic gastrointestinal diseases presented at the symposium.
摘要
嗜酸粒细胞性胃肠道疾病研究联合会（CEGIR）和国际胃肠道嗜酸粒细胞研究人员组织了一次为期一天的研讨会，在 2024 年美国过敏、哮喘和免疫学学会年会上举行。该研讨会的特色是基础和转化研究的新发现，以及对嗜酸粒细胞性胃肠道疾病的机制和管理的辩论。还介绍了最近临床试验和共识指南的更新。我们总结了研讨会上提出的关于嗜酸粒细胞性胃肠道疾病的最新进展。
相似文献
1
Advances and ongoing challenges in eosinophilic gastrointestinal disorders presented at the CEGIR/TIGERs Symposium at the 2024 American Academy of Allergy, Asthma & Immunology meeting.美国过敏、哮喘与免疫学学会 2024 年会议上 CEGIR/TIGERs 研讨会呈现的嗜酸性粒细胞性胃肠道疾病的进展和持续挑战。
J Allergy Clin Immunol. 2024 Oct;154(4):882-892. doi: 10.1016/j.jaci.2024.07.022. Epub 2024 Aug 5.
2
Breakthroughs in understanding and treating eosinophilic gastrointestinal diseases presented at the CEGIR/TIGERs Symposium at the 2022 American Academy of Allergy, Asthma & Immunology Meeting.在2022年美国过敏、哮喘与免疫学会会议的CEGIR/TIGERs研讨会上展示的嗜酸性胃肠道疾病在理解和治疗方面的突破。
J Allergy Clin Immunol. 2023 Dec;152(6):1382-1393. doi: 10.1016/j.jaci.2023.08.021. Epub 2023 Sep 3.
3
New developments in patients with eosinophilic gastrointestinal diseases presented at the CEGIR/TIGERS Symposium at the 2018 American Academy of Allergy, Asthma & Immunology Meeting.在 2018 年美国过敏、哮喘与免疫学学会会议上的 CEGIR/TIGERS 研讨会中展示了嗜酸细胞性胃肠道疾病患者的新进展。
J Allergy Clin Immunol. 2018 Jul;142(1):48-53. doi: 10.1016/j.jaci.2018.05.005. Epub 2018 May 24.
4
Advancing patient care through the Consortium of Eosinophilic Gastrointestinal Disease Researchers (CEGIR).通过嗜酸性粒细胞性胃肠病研究人员联合会（CEGIR）推进患者护理。
J Allergy Clin Immunol. 2020 Jan;145(1):28-37. doi: 10.1016/j.jaci.2019.11.012. Epub 2019 Nov 20.
5
Building and implementing a research infrastructure for eosinophilic gastrointestinal diseases.构建并实施嗜酸性胃肠道疾病的研究基础设施。
J Allergy Clin Immunol. 2024 Jun;153(6):1536-1539. doi: 10.1016/j.jaci.2024.04.014.
6
Eosinophilic Ascites: Singular Presentation of Eosinophilic Gastrointestinal Disorder.嗜酸性腹水：嗜酸性胃肠道疾病的独特表现
J Investig Allergol Clin Immunol. 2018 Aug;28(4):275-276. doi: 10.18176/jiaci.0260.
7
Common and disparate clinical presentations and mechanisms in different eosinophilic gastrointestinal diseases.不同嗜酸性粒细胞性胃肠道疾病的常见和不同临床表现及机制。
J Allergy Clin Immunol. 2024 Jun;153(6):1472-1484. doi: 10.1016/j.jaci.2024.03.013. Epub 2024 Mar 28.
8
Eosinophilic gastrointestinal disease below the belt.下消化道嗜酸性粒细胞性疾病。
J Allergy Clin Immunol. 2020 Jan;145(1):87-89.e1. doi: 10.1016/j.jaci.2019.10.013. Epub 2019 Oct 24.
9
Impressions and aspirations from the FDA GREAT VI Workshop on Eosinophilic Gastrointestinal Disorders Beyond Eosinophilic Esophagitis and Perspectives for Progress in the Field.美国食品和药物管理局关于嗜酸性胃肠道疾病除嗜酸性食管炎以外的 GREAT VI 研讨会的印象和愿望，以及该领域进展的观点。
J Allergy Clin Immunol. 2022 Mar;149(3):844-853. doi: 10.1016/j.jaci.2021.12.768. Epub 2021 Dec 22.
10
Histologic eosinophilic gastritis is a systemic disorder associated with blood and extragastric eosinophilia, TH2 immunity, and a unique gastric transcriptome.组织学嗜酸性胃炎是一种与血液和胃外嗜酸性粒细胞增多、TH2免疫及独特的胃转录组相关的全身性疾病。
J Allergy Clin Immunol. 2014 Nov;134(5):1114-24. doi: 10.1016/j.jaci.2014.07.026. Epub 2014 Sep 15.
引用本文的文献
1
Non-eosinophilic esophagitis eosinophilic gastrointestinal diseases are more prevalent than eosinophilic esophagitis in Korean children: from a multicenter study based on new diagnostic criteria and nomenclature.在韩国儿童中，非嗜酸性粒细胞性食管炎的嗜酸性粒细胞性胃肠疾病比嗜酸性粒细胞性食管炎更为普遍：基于新诊断标准和命名法的多中心研究。
Front Pediatr. 2025 Aug 14;13:1656107. doi: 10.3389/fped.2025.1656107. eCollection 2025.
2
Spatial Eosinophil Phenotypes as Immunopathogenic Determinants in Inflammatory Diseases.作为炎症性疾病免疫致病决定因素的空间嗜酸性粒细胞表型
Cells. 2025 Jun 5;14(11):847. doi: 10.3390/cells14110847.
3
Age-Dependent Clinical Manifestations of Eosinophilic Gastrointestinal Disorders Beyond Eosinophilic Esophagitis.嗜酸性食管炎之外的嗜酸性胃肠道疾病的年龄依赖性临床表现。
J Asthma Allergy. 2025 May 15;18:757-768. doi: 10.2147/JAA.S510375. eCollection 2025.
4
Reply.回复。
J Allergy Clin Immunol. 2025 Jan;155(1):240. doi: 10.1016/j.jaci.2024.09.026. Epub 2024 Nov 8.
本文引用的文献
1
Tissue-specific inducible IL-33 expression elicits features of eosinophilic esophagitis.组织特异性诱导性白细胞介素-33表达引发嗜酸性粒细胞性食管炎的特征。
J Allergy Clin Immunol. 2024 Dec;154(6):1545-1553.e2. doi: 10.1016/j.jaci.2024.08.026. Epub 2024 Sep 10.
2
Challenging assumptions about the demographics of eosinophilic gastrointestinal diseases: A systematic review.对嗜酸性胃肠道疾病人口统计学假设的挑战：一项系统评价。
J Allergy Clin Immunol Glob. 2024 Apr 16;3(3):100260. doi: 10.1016/j.jacig.2024.100260. eCollection 2024 Aug.
3
Dietary Management of Non-EoE Eosinophilic Gastrointestinal Diseases.非 EoE 嗜酸性粒细胞性胃肠道疾病的饮食管理。
Immunol Allergy Clin North Am. 2024 May;44(2):383-396. doi: 10.1016/j.iac.2024.01.009. Epub 2024 Feb 12.
4
Machine learning-based identification and characterization of mast cells in eosinophilic esophagitis.基于机器学习的嗜酸性粒细胞性食管炎中肥大细胞的识别与特征分析。
J Allergy Clin Immunol. 2024 May;153(5):1381-1391.e6. doi: 10.1016/j.jaci.2024.01.026. Epub 2024 Feb 22.
5
Lysyl Oxidase Regulates Epithelial Differentiation and Barrier Integrity in Eosinophilic Esophagitis.赖氨酰氧化酶调节嗜酸性粒细胞性食管炎中的上皮分化和屏障完整性。
Cell Mol Gastroenterol Hepatol. 2024;17(6):923-937. doi: 10.1016/j.jcmgh.2024.01.025. Epub 2024 Feb 9.
6
Epithelial overexpression of IL-33 induces eosinophilic esophagitis dependent on IL-13.上皮细胞中 IL-33 的过度表达依赖于 IL-13 诱导嗜酸性食管炎。
J Allergy Clin Immunol. 2024 May;153(5):1355-1368. doi: 10.1016/j.jaci.2024.01.017. Epub 2024 Feb 3.
7
Joint ESPGHAN/NASPGHAN Guidelines on Childhood Eosinophilic Gastrointestinal Disorders Beyond Eosinophilic Esophagitis.儿童嗜酸性粒细胞性胃肠道疾病除嗜酸性食管炎以外的 ESPGHAN/NASPGHAN 指南
J Pediatr Gastroenterol Nutr. 2024 Jan;78(1):122-152. doi: 10.1097/MPG.0000000000003877. Epub 2023 Jul 4.
8
Systematic identification of genotype-dependent enhancer variants in eosinophilic esophagitis.系统鉴定嗜酸性粒细胞性食管炎中与基因型相关的增强子变异。
Am J Hum Genet. 2024 Feb 1;111(2):280-294. doi: 10.1016/j.ajhg.2023.12.008. Epub 2024 Jan 5.
9
Barriers to Timely Diagnosis of Eosinophilic Gastrointestinal Diseases.嗜酸性胃肠道疾病及时诊断的障碍
J Allergy Clin Immunol Pract. 2024 Feb;12(2):302-308. doi: 10.1016/j.jaip.2023.12.020. Epub 2023 Dec 17.
10
Th2 cytokine signaling through IL-4Rα increases eotaxin-3 secretion and tension in human esophageal smooth muscle.Th2 细胞因子信号通过 IL-4Rα 增加人食管平滑肌中的嗜酸性粒细胞趋化因子-3 的分泌和张力。
Am J Physiol Gastrointest Liver Physiol. 2024 Jan 1;326(1):G38-G52. doi: 10.1152/ajpgi.00155.2023. Epub 2023 Nov 7.
Zotero 插件